Oncology & Cancer

SABCS: Extending tamoxifen to 10 years beneficial in breast CA

(HealthDay)—For women with estrogen receptor (ER)-positive early breast cancer, continuing tamoxifen to 10 years correlates with reduced risk of recurrence and lower breast cancer-specific and overall mortality, according ...

Oncology & Cancer

Most women who have double mastectomy don't need it, study finds

About 70 percent of women who have both breasts removed following a breast cancer diagnosis do so despite a very low risk of facing cancer in the healthy breast, new research from the University of Michigan Comprehensive ...

Oncology & Cancer

Improving confidence keeps breast cancer survivors exercising

(Medical Xpress)—More than 40 percent of older breast cancer survivors are insufficiently active after leaving a supervised program. But new research shows that those women who developed behavioral skills such as self-confidence ...

Oncology & Cancer

Outcomes similar with partial, whole breast irradiation

(HealthDay)—Accelerated partial breast irradiation (APBI) yields five-year clinical outcomes and patterns of failure similar to those achieved with whole breast irradiation (WBI), with excellent three-year survival for ...

Oncology & Cancer

Older women may not benefit from radiotherapy after breast surgery

A Rhode Island Hospital radiation oncologist says in a new editorial that research exploring the impact of radiotherapy in older women with low risk of breast cancer recurrence has little effect on actual clinical decisions. ...

page 13 from 21